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To the Editor: Since the late eighties, Chlamydia pneumoniae is considered as an agent of 
community-acquired pneumonia (CAP) and of other respiratory tract infections affecting all 
ages [1]. The common occurrence of C. pneumoniae infection is suggested by the high 
seroprevalence (> 70%) observed in adults [2]. However, in recent studies [3-5], the 
prevalence of respiratory infections due to C. pneumoniae was reported to be much lower 
(<1.5%) than previously (6-22%) [6]. This apparent decrease in C. pneumoniae infections 
prevalence could be due to changes in C. pneumoniae epidemiology over time, to increased 
specificity of new diagnostic methods or to the difficulty for clinicians to target the infected 
population. 
In our university hospital, we routinely use a multiplex real-time PCR for the detection of C. 
pneumoniae and Mycoplasma pneumoniae DNA [7]. From October 2001 to June 2010, a total 
of 2244 respiratory specimens retrieved from 1583 patients were sent to the laboratory for C. 
pneumoniae and/or M. pneumoniae PCR, including 884 bronchoalveolar lavages, 843 
nasopharyngeal swabs, 354 bronchial aspirates, 111 sputa and 52 other samples. Only 4 
(0.2%) samples taken from two patients were positive for C. pneumoniae, whereas 76 (3.4%) 
were positive for M. pneumoniae in 65 patients. In both cases, the diagnosis of C. pneumoniae 
infection was not suspected by the clinician and the test was done thanks to the multiplex 
format of our molecular test.  
The first patient with C. pneumoniae infection was a 48-year old man receiving 
immunosuppressive therapy for inflammatory bowel disease. He presented with a chronic 
cough initially suspected to be asthma and a febrile episode. PCRs performed on sputa 
obtained on day 0 and day 4 were highly positive with 2’285’300 copies/ml (Ct=24.6) and 
2’389’200 copies/ml (Ct=25). The amount of DNA decreased to 465 copies/ml (Ct=37.2) in 
17 days. In presence of persistent dry cough despite the falling bacterial load, clarithromycin 
500 mg bid was administered for 2 weeks. Clinical evolution was favorable under 
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antimicrobial therapy with rapid decrease of cough. Follow-up PCRs at day 34 and day 48 
were negative.  
The second patient with C. pneumoniae infection was a healthy 13-year old girl presenting 
with a third episode of pneumonia over a 5-month period. PCR performed on naso-pharyngeal 
swab was positive with 153 copies/ml (Ct=36.5). The patient condition improved with 
clarithromycin therapy. 
This study confirms that C. pneumoniae is rarely detected, at least in our setting, since only 2 
patients out of 1583 were identified with C. pneumoniae infection over a ten-year period. This 
may reflect a low prevalence of the disease and/or suggests that clinicians do not target the 
right population. The 2nd hypothesis is supported by the fact that both cases were not 
suspected by the physician in charge and the etiological diagnosis was made thanks to the 
duplex approach of our molecular test. Since C. pneumoniae infection may be associated with 
persistent cough in adults [8, 9], it should be included in the differential diagnosis of chronic 
cough and asthma.  
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